Results 211 to 220 of about 10,655,093 (390)
Advances and Strategies in Enhancing mRNA Cancer Vaccines
Messenger RNA (mRNA) vaccines offer a powerful approach for cancer immunotherapy, but their clinical impact remains limited by delivery challenges and suboptimal immune activation. This review discusses key biological barriers and design strategies—including structural optimization, immunomodulation, organ targeting delivery, and advanced nanocarriers ...
Miao Zhang+4 more
wiley +1 more source
PATHOPHYSIOLOGIC AND CLINICAL STUDY FOR DISEASES OF THE GASTROINTESTINAL TRACT
Shoichi Yamagata
openalex +2 more sources
Capsule endoscopy - State of the Technology and Computer Vision Tools after the First decade [PDF]
Mackiewicz, Michal
core +2 more sources
Bacteria‐Responsive Nanostructured Drug Delivery Systems for Targeted Antimicrobial Therapy
Bacteria‐responsive nanocarriers are designed to release antimicrobials only in the presence of infection‐specific cues. This selective activation ensures drug release precisely at the site of infection, avoiding premature or indiscriminate release, and enhancing efficacy.
Guillermo Landa+3 more
wiley +1 more source
Excretory function of the stomach in diseases of the gastrointestinal tract
R. S. Gelfenbein
openalex +2 more sources
Mesoporous Silica Nanoparticles in Biomedicine: Advances and Prospects
Mesoporous silica nanoparticles offer unique properties like high surface area, tunable pores, and functionalization. They excel in drug delivery, tissue engineering, and stimuli‐responsive therapies, enabling targeted and controlled treatments. With roles in cancer therapy and diagnostics, their clinical translation requires addressing challenges in ...
Miguel Manzano, María Vallet‐Regí
wiley +1 more source
Gastrointestinal: Celiac disease [PDF]
Roberts-Thomson Ic+2 more
openaire +3 more sources
Supported lipid bilayers coupled with multielectrode array devices offer significant promise for pathogen–host cell membrane interaction studies. This work demonstrates, for the first time, the compatibility of this platform with biological fluids, in this case whole human blood, essential for any future point‐of‐care applications; as well as its ...
Alexandra Wheeler+4 more
wiley +1 more source